ESLAW 8-K 2026-08-21

Estrella Immunopharma, Inc. (ESLAW) 8-K dated 2026-08-21 — accession 0001213900-26-092657.

Estrella Immunopharma, Inc. (ESLAW) is a biotechnology company listed on US.

Estrella Immunopharma, Inc. filed a 8-K on 2026-08-21. Accession 0001213900-26-092657.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ESLAW is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ESLAW SEC hub lists recent forms. The stock page is the research view.